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Abstract
31The improvement of commonly used Gd -based MRI contrast agents requires the design of new chelates with optimised in vivo
efficacy, pharmacokinetic properties and specificity. The molecular parameters determining the nuclear relaxivity of the cationic chelate
1 22[Gd(DO2A)] , as well as of some copolymers of [Gd(DTPA)] with diamines, were obtained using spectroscopic techniques. In both
cases, the resulting too slow inner-sphere water exchange rate limits the relaxivity increase expected, respectively, from an increased
water coordination number, and some degree of rotational restriction, although in the latter case, the relaxivity shows a maximum in the
30 MHz proton frequency region. The use of the polymeric compounds as MR angiography agents is limited by their fast uptake from the
111 31 153 31blood pool of Wistar rats. The use of scintigraphic diagnostic agents critically depends on their targeting properties. In and Sm
chelates of DTPA derivatives, containing albumin binding or hepato-specific synthons, show different organ specificity, albumin binding
111 31properties and excretion pathways and kinetics, as shown by biodistribution and gamma imaging studies of Wistar rats. The In ,
153 31 31 31 82Sm , Gd and Tm chelates of the tetraaza-phosphonate macrocycle DOTP also show high bone uptake specificity.
  2002 Elsevier Science B.V. All rights reserved.
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1 . Introduction tetraazacyclododecane-1,4,7,10-tetraacetate) (see Scheme
1).
31Chelates of Gd have found widespread application as The overwhelming success of the CAs and the rapid
contrast agents (CAs) for magnetic resonance imaging development of the MRI technique have given rise to a
31(MRI) [1–5]. The paramagnetic Gd ion in these com- continuing demand for new generations of CAs that are
pounds has an enhancing effect on the relaxation rate of more effective and selective. The molecular parameters
the water protons in its proximity, which may lead to an determining their nuclear relaxivity must be optimised, in
increase of the contrast in the images and a decrease of the order to maximize their efficiency. Following predictions
31imaging time. Encapsulation of Gd in a strongly chelat- of relaxation theory [1–5], we investigated in this work the
31ing ligand is necessary, since the Gd aquo ion is highly effect of an increase of the inner-sphere water coordination
toxic, whereas the chelates are not. Thus an important number (q) from 1 to 2 or 3, by studying the
31 1
requirement that a Gd complex must meet for in vivo [Ln(DO2A)] complexes (DO2A, 1,7-bis(carboxy
applicability is high stability, both thermodynamic and methyl)-1,4,7,10-tetraazacyclododecane, Scheme 1), re-
kinetic. The chelating ligand preferably should leave sulting from the elimination of two carboxylates from the
31
enough space on the Gd ion for coordination of water. ligand DOTA. Higher relaxation rates are also obtained
31The coordinated water exchanges with the bulk and as a upon increase of the rotational correlation time of the Gd
result an overall contrast enhancement (reduction of the complexes, which may be achieved by non-covalent or
31
water proton relaxation rate) may be obtained. Currently, covalent binding of low-molecular weight Gd chelates to
commercially available CAs are derivatives of: (i) DTPA macromolecules or polymers [3–5]. These conjugates
(DTPA, diethylenetriamine-N,N,N9,N0,N0-pentaacetate) might have prolonged residence time in the cardiovascular
and (ii) the macrocyclic ligand DOTA (DOTA, 1,4,7,10- system, with potential applications in MRI angiography
(MRA) [3–5]. We report the biophysical characterization
and in vivo pharmacokinetics in Wistar rats of two linear*Corresponding author.
E-mail address: geraldes@cygnus.ci.uc.pt (C.F.G.C. Geraldes). polyamide conjugates of Gd(III)-DTPA (Gd(DTPA–
0925-8388/02/$ – see front matter   2002 Elsevier Science B.V. All rights reserved.
PI I : S0925-8388( 02 )00295-5
5M.G. Duarte et al. / Journal of Alloys and Compounds 344 (2002) 4–8
Scheme 1.
HMD) and Gd(DTPA–CHD), Scheme 1), obtained by cific agents, respectively, using gamma imaging and
copolymerization of DTPA with two diamines. Further- biodistribution techniques in Wistar rats.
more, contrast improvements may be achieved by attach-
ing substituents on the ligand such that higher organ or
31tissue specificity is obtained [4,5]. New generations of CAs 2 . Optimizing Gd -based MRI contrast agents
are also being developed that are reporters of their
biochemical environment, allowing, for example, visuali- Relaxation theory shows that the currently commercially
zation of pH differences, oxygen concentrations, gene available CAs are far from optimal with regard to relaxa-
expression and therapeutic drug delivery [4,5]. tion enhancement. An improvement may be achieved via
The utility of scintigraphic diagnostic agents critically rational design of the ligands, which requires insight into
depends on their targeting properties, which are achieved the parameters that govern the relaxivity, r (enhancement1
21 21by adequate ligand design [6]. Two DTPA derivatives, a of the water proton relaxation rate, expressed in s mM
31
mono-amide derivative containing an iodinated synthon, Gd ). Extensive studies in this field [1–5] have shown
DTPA-IOPsp (3h[6[[[2-[(2aminoethyl)amino]ethyl]- that each of these parameters is related to the solution
amino]acetylamino] - 1 - oxo - ethylamino] -a - ethyl - 2,4,6- structures and dynamics of the concerning complexes.
triiodej benzene propanoic acid) and DTPA(BOM) Higher relaxivities may be achieved by, for example, (i)3
(h2 - (benzyloxymethyl) - 6,9 - bis(1 - carboxy - 2-benzyl- the design of the environment of the water coordination
oxyethyl)-3,9-bis-(carboxymethyl)-3,6,9-triazajundecanoic site, so that the water exchange rate will not limit the
111 31
acid) (Scheme 1), radiolabelled with In and overall relaxivity (t ,T , with t being the residencem 1m m
153 31 111 31 153 31Sm , and the In and Sm chelates of the time of a water molecule in the first coordination sphere,
82tetraaza-phosphonate macrocycle DOTP (1,4,7,10- and T the water proton longitudinal relaxation time), (ii)1m
tetraazacyclododecane - 1,4,7,10 - tetramethyl- an increase of the molecular weight of the compounds, in
enephosphonate, Scheme 1) were studied as potential order to increase the rotational correlation time, t , (iii) anR
hepatospecific gamma scintigraphic agents and bone-spe- increase of the rigidity of the complex, which gives rise to
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31 21
an increase of the electronic relaxation time of the Gd s for B 50.34 T). The values of all these parameterso
ion, t , or (iv) an increase of the inner-sphere water have an adverse effect on the expected increase of thes0
1
coordination number (q) from 1 to 2 or 3. proton relaxivity of the [Gd(DO2A)(H O) ] complex2 2,3
2An important drawback of [Gd(DOTA)(H O)] containing a hydration equilibrium among several inner2
(DOTAREM, Guerbet, France), which is common to all sphere water molecules.
extracellular contrast agents, is the lack of any tissue- Another way of obtaining higher relaxivities is by
31
specificity. Attempts to obtain tissue-specific MRI contrast increasing the rotational correlation time, t , of the GdR
agents have led to the synthesis of positively charged complexes, through their covalent or non-covalent binding
Gd(III) complexes which proved promising in bone target- to macromolecules or polymers. Thus, several blood pool
ing by their ability to mimic the interaction of biological CAs for MRA examinations have been developed, through
21 31
cations (e.g. Ca ) with the anionic bone surface [7]. The conjugation of low molecular weight Gd -chelate com-
22 2
elimination of two carboxylates from the ligand DOTA plexes, such as Gd(DTPA) or Gd(DOTA) , to natural or
results in a decreased stability of the corresponding synthetic polymeric materials, like polysaccharides, human
1[Ln(DO2A)] complexes, but the increased number of serum albumin (HSA), polyaminoacids like polylysine and
inner-sphere water molecules may significantly increase polyornithine or dendrimers [5]. Some linear polymers of
1the relaxivity of the [Gd(DO2A)] complex. The solution DTPA have also been prepared in which the chelate is
1
structure and dynamics of the [Ln(DO2A)(H O) ] com- incorporated directly in the polymeric chain [11]. We2 q
1 17
synthesised two of such linear polyamide conjugates ofplexes have been studied by H and O NMR, relax-
22Gd(DTPA) , where the polymeric ligands were obtainedometry, UV-vis and luminescence [8,9]. The smaller extent
31 by copolymerization of DTPA with two different diamines,of encapsulation of the Ln ions by the DO2A ligand
the linear and conformationally flexible 1,6-hexanediamineleads to a less rigid macrocyclic [3333] structure than in
1 (HMD) and the cyclic and conformationally more rigidthe DOTA chelates, as indicated by the H NMR reso-
trans-1,4-cyclohexadiamine (CHD) [12]. The polymersnances of its CH protons [8]. Luminescence studies have2
DTPA–HMD and DTPA–CHD (Scheme 1) were char-shown that one of the inner-sphere water molecules of the
31
acterised by high resolution nuclear magnetic resonanceEu chelate hydrolyses at slightly basic pH with a pK ofh
(NMR) spectroscopy and size exclusion chromatography8.160.3 [9].
(SEC), showing low polydispersity. Their molecular flex-We studied the hydration state of the whole series of
131 ibility in solution was studied using C spin-lattice[Ln(DO2A)] complexes in aqueous solution at pH 7.0 by
17
relaxation time measurements, indicating that the cyclo-measuring their water lanthanide induced O shifts (LIS).
hexanediamine linking moiety of the DTPA–HMD poly-Their contact contribution indicates a decrease of the
mer is more rigid than that of DTPA–CHD. The influenceinner-sphere water coordination number of the
1
of the flexibility of the linking functionalities on the[Ln(DO2A)(H O) ] complexes from q53 for Ln52 q
31
relaxivity of the Gd -DTPA–polymer conjugates wasCe→Eu, to q52, for Ln5Tb→Yb [10]. A temperature-
7 5
studied by water nuclear magnetic relaxation dispersiondependent UV-vis study of the 578–582 nm F → D0 0
1 (NMRD). The relaxivity of the [Gd(DTPA–CHD)] poly-transition band of [Eu(DO2A)(H O) ] in aqueous solu-2 q
mer was only slightly higher than that of the [Gd(DTPA–tion, shows that this complex is present in an equilibrium
HMD)] polymer, and only two times higher than the usualbetween eight- and nine-coordinate species with q52 and
values for small Gd-DTPA-like chelates. The low relax-q53:
ivities obtained for both polymers, much lower than
1 1[Eu(DO2A)(H O) ] 1H O⇔[Eu(DO2A)(H O) ] (1)2 2 2 2 3 expected from the polymer apparent molecular weights,
result from their substantial residual flexibility due to the
298The hydration equilibrium parameters obtained, K 5 rapid internal rotational motion of the linking moietiesEu
21 31(4.060.2), DH852(12.161) kJ mol and DS852 between the Gd -chelate in the polymeric chain, and also
21 21(28.963) J mol K , correspond to an average coordi- from a too long, non-optimal, value of the inner-sphere
nation number of 2.65–2.85 in the temperature range water exchange rate [12]. The in vivo pharmacokinetics of
273–363 K [10]. We also used a variable temperature, these polymeric compounds in Wistar rats was studied by
17
multiple field O NMR study combined with direct EPR the decay of blood relaxivity with the time after injection
measurements of the transverse electronic relaxation rates of the polymers, showing very short blood half-lifes, t |1 / 2
to obtain the parameters determining the proton relaxivity 20 min. Their very fast clearance from blood indicates that
1
of [Gd(DO2A)(H O) ] . The limited increase in its these flexible, hydrophilic, polymeric compounds are of2 2,3
298 6 21 limited value as blood pool CAs for MRA.water exchange rate, k 5(1065)310 s , as comparedex
2 6 21to [Gd(DOTA)(H O)] (4.8310 s ), is the consequence2
of two opposite effects: a decrease from the positive
3 . Targeting CAs and scintigraphic agentscharge and an increase from the existence of the hydration
298
equilibrium. The value of t 54061 ps is short, and theR
10 21 New CAs, more efficient than the unspecific intracellu-electronic relaxation rate (1 /T |1.2310 s ) is rela-2e
2 9 lar ones, are being developed that may be directed totively fast relative to [Gd(DOTA)(H O)] (1.3–2.43102
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153 31targets of interest, thereby achieving higher local con- The Sm chelates are also more hepatospecific than the
111 31
centrations at lower dosages. Examples are CAs that are corresponding In chelates, due to different structures
specific for organs, diseased tissue or that are able to in solution, as studied by NMR [15].
recognize particular biochemicals. Usually, this is achieved Since highly charged phosphonates are known to local-
22 153 52by functionalization of the ligands in [Gd(DTPA)] and ize on bone surfaces [16], [ Sm(EDTMP)] (EDTMP,
2[Gd(DOTA)] type complexes. For example, complexes ethylenediamino-tetramethylenephosphonate) is used as a
22 31
of DTPA with lipophilic side chains ([Gd(BOPTA)] palliative agent for painful bone metastasis [17]. The Ln
22(Multihance, Bracco) and [Gd(EOB-DTPA)] complexes of the tetraaza-phosphonate macrocycle
82 52(Eovist, Schering), Scheme 1) have been introduced as DOTP , [Ln(DOTP)] , are very stable and well char-
52hepatobiliary CAs [5], as they undergo .35% biliary acterized in solution and [Tm(DOTP)] is a very good
23 1
excretion and enter the hepatocytes via a combination of shift reagent for Na NMR of isolated cells, perfused
52passive diffusion and a carrier-mediated mechanism [5]. tissues and intact animals [5]. Although [Tm(DOTP)] ,
High molecular weight compounds and liposomes have after injection in Wistar rats, is cleared from plasma more
31
also shown potential as CAs for lymphography [5]. rapidly than typical lower charged Gd -based contrast
Studies on potential tumor-specific CAs based on conju- agents, about 18% is retained for at least 3 h in one very
gates of antibodies attached to conjugates of polymeric slow equilibrating space, from which it is cleared very
31
carriers and low molecular Gd chelates have been slowly compared to renal clearance [18]. The assumption
52
reported [5]. An alternative approach takes advantage of that this 18% [Tm(DOTP)] remains bound to bone after
the negative charge of certain tumors, whereby positively the 3-h washout period was confirmed by gamma sci-
159 52
charged poly(amino acids) such as polyornithine or poly- ntigraphic biodistribution studies of [ Gd(DOTP)] in
arginine are selectively bound, which on their turn may rats, which found that 55% of the total injected radioactive
31
serve as targets for a negatively charged Gd chelate, dose was localized on bone surfaces after 30 min [19].
such as a DO3A derivative containing an additional Similar results were obtained by us in biodistribution
153 52 111 52pendant arm with phosphonate and carboxylate groups [5]. studies of [ Sm(DOTP)] and [ In(DOTP)] in
Another strategy for selective delivery of CAs at cancer Wistar rats. For example, in the second case about 25% of
cells exploits the intrinsic overexpression of sialic acid in the total injected radioactive dose was found localized on
them. Upon incubation of cancer cells with peracetylated bone surfaces after 48 h [20].
N-levulinoylmannosamine, the sialoside biosynthetic path-
way affords N-levulinoyl sialic acid, the ketone group of
31
which can be a target for a Gd complex of an aminooxy- A cknowledgements
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